Anna Litsiou
Director, Regulatory Policy & Intelligence AstraZeneca
Seminars
Tuesday 24th February 2026
Panel Discussion: Current Efforts to Spearhead Regulatory Modernisation & Acceptance of Novel CGT Technologies
11:00 am
- Share how regulators in Europe, the US, and Asia are adapting frameworks to keep pace with emerging cell and gene therapy technologies
- Highlight initiatives that foster earlier and more constructive engagement
- Understand how modernisation efforts can accelerate approvals, support broader adoption, and make CGTs more commercially viable
Tuesday 24th February 2026
Navigating Asia–EMA Regulatory Pathways to Accelerate Global Development
10:00 am
- Compare regulatory frameworks, approval pathways, and clinical trial requirements across key Asian markets and the EMA
- Identify opportunities to streamline global development by leveraging Asia’s evolving regulatory landscape
- Highlight emerging opportunities for biotechs to expand into Asian markets through collaborative or parallel regulatory approaches
